B
Barbara A. Cornblatt
Researcher at The Feinstein Institute for Medical Research
Publications - 289
Citations - 16349
Barbara A. Cornblatt is an academic researcher from The Feinstein Institute for Medical Research. The author has contributed to research in topics: Psychosis & Prodrome. The author has an hindex of 63, co-authored 253 publications receiving 14246 citations. Previous affiliations of Barbara A. Cornblatt include Hofstra University & Yale University.
Papers
More filters
Journal ArticleDOI
Duration of the psychosis prodrome.
Albert R. Powers,Jean Addington,Diana O. Perkins,Carrie E. Bearden,Kristin S. Cadenhead,Tyrone D. Cannon,Barbara A. Cornblatt,Daniel H. Mathalon,Larry J. Seidman,Ming T. Tsuang,Elaine F. Walker,Thomas H. McGlashan,Scott W. Woods +12 more
TL;DR: Analysis of data from the second North American Prodrome Longitudinal Study (NAPLS-2) provides the most precise estimate of prodrome duration to date, although results are limited to prodromes identified by ascertainment as being at CHR-P.
Journal ArticleDOI
The Field of Schizophrenia: Strengths, Weaknesses, Opportunities, and Threats
John M. Kane,Barbara A. Cornblatt,Christoph U. Correll,Terry E. Goldberg,Todd Lencz,Anil K. Malhotra,Delbert G. Robinson,Philip R. Szeszko +7 more
TL;DR: This issue commemorates the seminal contributions of Eugene Bleuler and is confronted with a climate in which the lay press finds occasion to call into question the very real progress that has been made in the understanding and treatment of mental illnesses.
Journal ArticleDOI
Overview of the First Annual Workshop on the Schizophrenia Prodrome
TL;DR: This report summarizes the five major topics discussed throughout the workshop: (1) vulnerability and risk factors, (2) developmental issues, (3) neuroimaging and cognition, (4) alternative prevention strategies, and (5) clinical trials.
Journal ArticleDOI
White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis.
Maria A Di Biase,Maria A Di Biase,Suheyla Cetin-Karayumak,Amanda E. Lyall,Amanda E. Lyall,Andrew Zalesky,Kang Ik Kevin Cho,Fan Zhang,Marek Kubicki,Marek Kubicki,Yogesh Rathi,Monica Lyons,Sylvain Bouix,Tashrif Billah,Alan Anticevic,Charlie Schleifer,Brendan Adkinson,Jie Lisa Ji,Zailyn Tamayo,Jean Addington,Carrie E. Bearden,Barbara A. Cornblatt,Barbara A. Cornblatt,Matcheri S. Keshavan,Daniel H. Mathalon,Daniel H. Mathalon,Thomas H. McGlashan,Diana O. Perkins,Diana O. Perkins,Kristen Cadenhead,Ming T. Tsuang,Scott W. Woods,William S. Stone,Martha E. Shenton,Martha E. Shenton,Tyrone D. Cannon,Ofer Pasternak +36 more
TL;DR: In this paper, the authors track the evolution of white matter abnormalities in a large, longitudinal cohort of clinical high risk individuals comprising the North American Prodrome Longitudinal Study (NAPLS-3) and fit linear mixed effects models to infer the impact of age and illness onset on variation in the fractional anisotropy of cellular tissue and the volume fraction of extracellular free water (FW).
Journal ArticleDOI
Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis.
Cynthia Z. Burton,Ivy F. Tso,Ricardo E. Carrión,Tara A. Niendam,Steven Adelsheim,Andrea M. Auther,Barbara A. Cornblatt,Cameron S. Carter,Ryan P. Melton,Tamara G. Sale,Stephan F. Taylor,William R. McFarlane,William R. McFarlane +12 more
TL;DR: Baseline negative symptoms and thought disorder appear to predict functional outcome for up to two years among adolescents and young adults at risk for psychosis and developing effective interventions to target these symptoms may be critical to promote functional recovery.